Physician profile
Robert P Roye
NPI 1306848866
$3,759.78
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $947 · 2020: $947 · 2021: $239 · 2022: $1,626.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,038.17 | 2020-2022 | |
| Stryker Corporation | $480.91 | 2019-2022 | |
| Trice Medical, INC. | $374.00 | 2019 | |
| Smith+Nephew, INC. | $239.79 | 2019-2022 | |
| Ortho Development Corporation | $177.46 | 2022 | |
| Abbvie INC. | $107.35 | 2021-2022 | |
| Bioventus LLC | $88.94 | 2019-2022 | |
| Ermi LLC | $72.39 | 2019 | |
| Dynasplint Systems INC. | $33.16 | 2022 | |
| Horizon Therapeutics Plc | $29.94 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $25.04 | 2020 | |
| Nevro Corp. | $18.68 | 2022 | |
| Acell, INC. | $17.58 | 2020 | |
| Pfizer INC. | $16.13 | 2019 | |
| Biodelivery Sciences International, INC. | $14.82 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $13.75 | 2019 | |
| Osiris Therapeutics INC. | $11.67 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Roye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.